Clinical Trial Update: Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial comparing dobutamine and regadenoson for stress cardiac MR; the study is terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Asthma
• Chronic Obstructive Pulmonary Disease
• Coronary Artery Disease

Drugs mentioned

• Dobutamine (dobutamine)
• Regadenoson (Regadenoson)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Coronary Artery Disease, Asthma | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2018-09-26